Pharmaceutical Firm and Solve.Care Partner to Develop Blockchain Network for Helping Diabetics
- Pharmaceutical firm Boehringer Ingelheim to work with Solve.care to develop distributed ledger technology (DLT)-enabled solution for diabetes patients.
- In particular, Germany-headquartered pharmaceutical company, Boehringer Ingelheim has partnered with blockchain-focused healthcare platform, Solve.
- Care for said service, which is tailored to meet the needs of diabetic patients and promoted data sharing.
Read full article: bitcoinexchangeguide.com